Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Everett

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Diabetes, Obesity & Metabolism|May 28, 2026
Impact of Removing Restrictive Haemoglobin A1C Eligibility Criteria for Insulin Pump Therapy Funding for Children With Type 1 Diabetes in Ontario, CanadaAlanna Weisman, Karl Everett, Peter C Austin, et al.
Diabetes Technology & Therapeutics|March 25, 2024
Recent Improvements in Attainment of the Hemoglobin A1c Target of ≤7.0% Among Adults with Type 1 Diabetes in Ontario: A Retrospective Cohort StudyAlanna Weisman, Gillian L Booth, Karl Everett, et al.
Obstetrics and Gynecology|November 2, 2023
New Persistent Opioid Use After ChildbirthJonathan S Zipursky, Karl Everett, Andrew Calzavara, et al.
Annals of Surgical Oncology|June 29, 2023
The Association Between Pregnancy Timing and Cumulative Exposure on Survival in MelanomaSarah B Bateni, Rinku Sutradhar, Karl Everett, et al.
CMAJ Open|June 14, 2022
Introduction of publicly funded pharmacare and socioeconomic disparities in glycemic management in children and youth with type 1 diabetes in Ontario, Canada: a population-based trend analysisMohana Giruparajah, Karl Everett, Baiju R Shah, et al.
Diabetes, Obesity & Metabolism|January 27, 2026
Timing of insulin pump initiation among individuals with type 1 diabetes in Ontario, CanadaXi Zhu, Lorraine L Lipscombe, Rayzel Shulman, et al.
Addiction (Abingdon, England)|March 13, 2024
A population-based time-series analysis of opioid agonist treatment dispensed during pregnancyRose A Schmidt, Karl Everett, Amaya Perez-Brumer, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|April 8, 2022
Preeclampsia and Severe Maternal Morbidity During the COVID-19 Pandemic: A Population-Based Cohort Study in Ontario, CanadaJohn W Snelgrove, Andrea N Simpson, Rinku Sutradhar, et al.
JAMA Network Open|May 12, 2021
Perinatal Outcomes During the COVID-19 Pandemic in Ontario, CanadaAndrea N Simpson, John W Snelgrove, Rinku Sutradhar, et al.
Diabetes, Obesity & Metabolism|June 24, 2025
Impact of social disadvantage on clinical and health care use indicators in adults with type 1 diabetes using insulin pumps in Ontario, CanadaYoustina Soliman, Karl Everett, Rayzel Shulman, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Diabetes, Obesity & Metabolism|May 28, 2026
Impact of Removing Restrictive Haemoglobin A1C Eligibility Criteria for Insulin Pump Therapy Funding for Children With Type 1 Diabetes in Ontario, CanadaAlanna Weisman, Karl Everett, Peter C Austin, et al.
Diabetes Technology & Therapeutics|March 25, 2024
Recent Improvements in Attainment of the Hemoglobin A1c Target of ≤7.0% Among Adults with Type 1 Diabetes in Ontario: A Retrospective Cohort StudyAlanna Weisman, Gillian L Booth, Karl Everett, et al.
Obstetrics and Gynecology|November 2, 2023
New Persistent Opioid Use After ChildbirthJonathan S Zipursky, Karl Everett, Andrew Calzavara, et al.
Annals of Surgical Oncology|June 29, 2023
The Association Between Pregnancy Timing and Cumulative Exposure on Survival in MelanomaSarah B Bateni, Rinku Sutradhar, Karl Everett, et al.
CMAJ Open|June 14, 2022
Introduction of publicly funded pharmacare and socioeconomic disparities in glycemic management in children and youth with type 1 diabetes in Ontario, Canada: a population-based trend analysisMohana Giruparajah, Karl Everett, Baiju R Shah, et al.
Diabetes, Obesity & Metabolism|January 27, 2026
Timing of insulin pump initiation among individuals with type 1 diabetes in Ontario, CanadaXi Zhu, Lorraine L Lipscombe, Rayzel Shulman, et al.
Addiction (Abingdon, England)|March 13, 2024
A population-based time-series analysis of opioid agonist treatment dispensed during pregnancyRose A Schmidt, Karl Everett, Amaya Perez-Brumer, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|April 8, 2022
Preeclampsia and Severe Maternal Morbidity During the COVID-19 Pandemic: A Population-Based Cohort Study in Ontario, CanadaJohn W Snelgrove, Andrea N Simpson, Rinku Sutradhar, et al.
JAMA Network Open|May 12, 2021
Perinatal Outcomes During the COVID-19 Pandemic in Ontario, CanadaAndrea N Simpson, John W Snelgrove, Rinku Sutradhar, et al.
Diabetes, Obesity & Metabolism|June 24, 2025
Impact of social disadvantage on clinical and health care use indicators in adults with type 1 diabetes using insulin pumps in Ontario, CanadaYoustina Soliman, Karl Everett, Rayzel Shulman, et al.
Pageof 5